Euthanasia in Belgium: Shortcomings of the Law and Its Application and of the Monitoring of Practice.

Belgium ethical analysis euthanasia law shortcomings

Journal

The Journal of medicine and philosophy
ISSN: 1744-5019
Titre abrégé: J Med Philos
Pays: United States
ID NLM: 7610512

Informations de publication

Date de publication:
25 01 2021
Historique:
entrez: 25 1 2021
pubmed: 26 1 2021
medline: 29 10 2021
Statut: ppublish

Résumé

In 2002 with the passing of the Euthanasia Law, Belgium became one of the few countries worldwide to legalize euthanasia. In the 18 years since the passing of the law, much has changed. We argue that in Belgium a widening of the use of euthanasia is occurring and that this can be ethically and legally problematic. This is in part related to the fact that several legal requirements intended to operate as safeguards and procedural guarantees in reality often fail to operate as such. We focus on three kinds of safeguards or procedural guarantees: (1) the legally defined due care criteria for eligibility for euthanasia; (2) the consultation of a second (and sometimes third) physician; and (3) the reporting of euthanasia cases to the Federal Control and Evaluation Commission for Euthanasia. We will show how each of these three safeguards can exhibit shortcomings in theory and practice.

Identifiants

pubmed: 33491735
pii: 6118631
doi: 10.1093/jmp/jhaa031
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-107

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press, on behalf of the Journal of Medicine and Philosophy Inc. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Kasper Raus (K)

Ghent University Hospital, Ghent, Belgium.

Bert Vanderhaegen (B)

Ghent University Hospital, Ghent, Belgium.

Sigrid Sterckx (S)

Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH